These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10644995

  • 1. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
    Zisch AH, Pazzagli C, Freeman AL, Schneller M, Hadman M, Smith JW, Ruoslahti E, Pasquale EB.
    Oncogene; 2000 Jan 13; 19(2):177-87. PubMed ID: 10644995
    [Abstract] [Full Text] [Related]

  • 2. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.
    Zisch AH, Kalo MS, Chong LD, Pasquale EB.
    Oncogene; 1998 May 13; 16(20):2657-70. PubMed ID: 9632142
    [Abstract] [Full Text] [Related]

  • 3. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ, Gale NW, Gish GD, Roth RA, Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD, Pawson T.
    EMBO J; 1997 Jul 01; 16(13):3877-88. PubMed ID: 9233798
    [Abstract] [Full Text] [Related]

  • 4. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH, Zisch AH, Dodelet VC, Pasquale EB.
    Oncogene; 2001 Jul 05; 20(30):3995-4006. PubMed ID: 11494128
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
    Elowe S, Holland SJ, Kulkarni S, Pawson T.
    Mol Cell Biol; 2001 Nov 05; 21(21):7429-41. PubMed ID: 11585923
    [Abstract] [Full Text] [Related]

  • 6. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C, Kasmi F, Ganju P, Walls E, Panayotou G, Reith AD.
    Oncogene; 1996 Apr 18; 12(8):1727-36. PubMed ID: 8622893
    [Abstract] [Full Text] [Related]

  • 7. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY, Harte RA, Cartwright CA.
    Oncogene; 2002 Oct 31; 21(50):7619-29. PubMed ID: 12400005
    [Abstract] [Full Text] [Related]

  • 8. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites.
    Smalla M, Schmieder P, Kelly M, Ter Laak A, Krause G, Ball L, Wahl M, Bork P, Oschkinat H.
    Protein Sci; 1999 Oct 31; 8(10):1954-61. PubMed ID: 10548040
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.
    Choi S, Park S.
    Oncogene; 1999 Sep 23; 18(39):5413-22. PubMed ID: 10498895
    [Abstract] [Full Text] [Related]

  • 10. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR, Oo ML, Senga T, Suzuki N, Feng GS, Hamaguchi M.
    Cancer Res; 2003 Oct 01; 63(19):6334-9. PubMed ID: 14559821
    [Abstract] [Full Text] [Related]

  • 11. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 2000 Jun 02; 299(2):521-35. PubMed ID: 10860756
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
    Wang XB, Lee H, Capozza F, Marmon S, Sotgia F, Brooks JW, Campos-Gonzalez R, Lisanti MP.
    Biochemistry; 2004 Nov 02; 43(43):13694-706. PubMed ID: 15504032
    [Abstract] [Full Text] [Related]

  • 13. Interaction of EphB2-tyrosine kinase receptor and its ligand conveys dorsalization signal in Xenopus laevis development.
    Tanaka M, Wang DY, Kamo T, Igarashi H, Wang Y, Xiang YY, Tanioka F, Naito Y, Sugimura H.
    Oncogene; 1998 Sep 24; 17(12):1509-16. PubMed ID: 9794228
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992.
    Holbrook MR, O'Donnell JB, Slakey LL, Gross DJ.
    Biochemistry; 1999 Jul 20; 38(29):9348-56. PubMed ID: 10413509
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP, Henkemeyer M, Nikolov DB.
    Nature; 1998 Dec 03; 396(6710):486-91. PubMed ID: 9853759
    [Abstract] [Full Text] [Related]

  • 16. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region.
    Wybenga-Groot LE, Baskin B, Ong SH, Tong J, Pawson T, Sicheri F.
    Cell; 2001 Sep 21; 106(6):745-57. PubMed ID: 11572780
    [Abstract] [Full Text] [Related]

  • 17. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J, Elowe S, Nash P, Pawson T.
    J Biol Chem; 2003 Feb 21; 278(8):6111-9. PubMed ID: 12486127
    [Abstract] [Full Text] [Related]

  • 18. Signal transfer by Eph receptors.
    Kalo MS, Pasquale EB.
    Cell Tissue Res; 1999 Oct 21; 298(1):1-9. PubMed ID: 10555534
    [Abstract] [Full Text] [Related]

  • 19. The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.
    Labrador JP, Brambilla R, Klein R.
    EMBO J; 1997 Jul 01; 16(13):3889-97. PubMed ID: 9233799
    [Abstract] [Full Text] [Related]

  • 20. Regulation of mRNA splicing and transport by the tyrosine kinase activity of src.
    Gondran P, Dautry F.
    Oncogene; 1999 Apr 22; 18(16):2547-55. PubMed ID: 10353598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.